Desta KassuMillion Yihenew2018-07-032023-11-062018-07-032023-11-062017-06http://etd.aau.edu.et/handle/123456789/6049Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are hepatotropic viruses whoseprimary replication occurs in the liver. A range of extrahepatic manifestations such as arthralgias,thyroiditis and diabetes are linked with HCV infections. Patients with diabetes mellitus arepredisposed to develop a spectrum of liver diseases. Objective: To determine the burden of Hepatitis B and Hepatitis C virus and their associatedFactors among diabetes patients attending University of Gondar Referral Teaching Hospital,Northwest Ethiopia. Methods: A comparative cross sectional study design was employed on 305 diabetes and 305diabetes free individuals from October 2016 to February 2017. Pre-tested structured interviewerbased questionnaire was used to collect data. Blood specimen was collected and serum wasseparated to determine hepatitis B surface antigen (HBsAg) and anti-HCV by Enzyme linkedimmunosorbent Assay (ELISA) assay. Data were entered with epidata; then exported to, clearedand analyzed by the statistical software SPSS version 20. Univariable and multivariable logisticregression analyses were performed to identify factors that contribute to the occurrence ofHepatitis B and Hepatitis C viral infections. Statistical significance was considered whenever p-value was less than 0.05. Result: Out of the total, 10.7% was found to be positive for Hepatitis infections, of which 14.43% and 6.89% study participants were sero-positive for at least one of the viruses in diabetes andcontrol groups respectively. The sero-positivity of Hepatitis B was 8.5% and 4.6% (95% CI, 0.96- 4.02); and Hepatitis C viral infections 7.5% and 2.3% (95%CI, 1.46 - 8.68) in diabetes and controlgroups respectively. History of blood transfusion (95% CI, 1.36 - 12.71) and unprotected sex (95%CI, 1.25 - 10.15) were found to be significantly associated with HBsAg sero-positivity and type ofdiabetes (95% CI, 1.25 - 10.89) was independently associated with anti-HCV seropositivity. Conclusion and recommendation: Even though no statistically significant difference detected inHBV infection, the sero-positivity against anti- HCV antibody in diabetes and controls groups wasfound to be 7.5% and 2.3%, respectively and the difference was statistically significant (p-value<0.001). Prospective studies are needed to confirm temporal association and elucidate the reasonsof association between DM and Hepatitis B and C viruses. Key words፡ HBV, HCV, DM, Coinfection, University of Gondar Referral Teaching HospitalenHBV HCV DMCoinfectionUniversity of Gondar Referral Teaching HospitalHepatitis B and Hepatitis C Viral Infections and Their Associated Factors Among Diabetes Patients Attending University of Gondar Referral Teaching Hospital, Northwest EthiopiaThesis